Analog Devices Impairment and restructuring decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $1.75M to $0.00. Over 4 years (FY 2021 to FY 2025), Impairment and restructuring shows a downward trend with a -4.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
High levels indicate significant operational disruption or strategic realignment, often impacting short-term profitability.
The aggregate expense recognized for asset write-downs and costs associated with restructuring operations, such as facil...
Frequently used by capital-intensive firms to isolate non-recurring costs from core operating performance.
msft_impairment_and_restructuring| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $311.00K | -$8.94M | $92.65M | $59.73M | $46.67M | $138.20M | $29.91M | $0.00 | $23.14M | $23.54M | $114.04M | $16.14M | $5.98M | $12.28M | $2.86M | $63.89M | $1.75M | $4.35M | $0.00 | $47.98M | $0.00 |
| QoQ Change | — | <-999% | >999% | -35.5% | -21.9% | +196.1% | -78.4% | -100.0% | — | +1.7% | +384.5% | -85.8% | -63.0% | +105.5% | -76.7% | >999% | -97.3% | +149.2% | -100.0% | — | -100.0% |
| YoY Change | — | — | — | — | >999% | >999% | -67.7% | -100.0% | -50.4% | -83.0% | +281.3% | — | -74.2% | -47.8% | -97.5% | +295.8% | -70.8% | -64.6% | -100.0% | -24.9% | -100.0% |
| Segment | Q2 '26 |
|---|---|
| Reportable Segment | $0.00 |
| Total | $0.00 |